- Taxans-anticancer drugs with a unique mechanism of action2000 | Faculty of Science
- Taxans-anticancer drugs with a unique mechanism of action2000 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Research Report University Hospital clinical trial BO28407Publication without faculty affiliation
- Úloha taxanů v terapii H and N karcinomůPublication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. Final report of University Hospital Hradec Kralove to the clinical trial protocol no. BO28407Publication without faculty affiliation
- Cardiotoxicity of antitumor drugs in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- History of chemotherapy2013 | First Faculty of Medicine
- Inflammatory breast cancer2008 | Central Library of Charles University
- Inflammatory breast cancer2008 | Publication without faculty affiliation
- Volasertib (BI 6727) and its possible role in anti-tumour therapy2011 | First Faculty of Medicine
- News in anti-HER2 targeted therapy in breast cancer +12013 | First Faculty of Medicine
- Urinary neopterin, serum retinol, alpha-tocopherol and homocysteine in breast cancer patients during treatment with bevacizumab and chemotherapy2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Report of University Hospital Hradec Králové to the clinical trial protocol No: BO28407Publication without faculty affiliation
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine
- Radiation-223 Treatment of a 72-year-old Patient with Castration-Resistant Prostate Cancer and Painful Bone Metastases2019 | Faculty of Medicine in Hradec Králové
- Nab-paclitaxel in neoadjuvant treatment of breast cancer2018 | First Faculty of Medicine
- Systemic treatment of metastatic gastric cancer2021 | Publication without faculty affiliation
- Trastuzumab emtansin v léčbě časného karcinomu prsu2021 | First Faculty of Medicine
- Cabazitaxel v léčbě metastazujícího karcinomu prostaty2018 | First Faculty of Medicine
- Expression of multidrug resistance gene 1 (MDR1) and its association with development and clinical outcome of breast carcinoma2007 | Second Faculty of Medicine
- Chemotherapy during pregnancy2009 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Immunotherapy in the treatment of esophageal and gastric tumors2022 | Third Faculty of Medicine
- Neoadjuvant treatment of early breast cancer2019 | Publication without faculty affiliation
- Trastuzumab deruxtecan: strong player in the field of metastatic HER2 positive breast cancer2022 | First Faculty of Medicine
- Postavení cetuximabu v léčbě recidivujícího/metastazujícího spinocelulárního karcinomu hlavy a krku (R/M HNSCC)2021 | First Faculty of Medicine
- AR-V7 androgen receptor variant as a predictor of response to androgen-receptor targeting agents used to treat castration-refractory metastatic prostate cancer2018 | First Faculty of Medicine
- Význam hormonálních léčiv v sekvenční léčbě metastazujícího CRPC2015 | Third Faculty of Medicine
- Pregnancy-associated breast cancer2016 | First Faculty of Medicine
- Alopecia and hair damage induced by oncological therapy2019 | Faculty of Medicine in Pilsen
